Background: Previous costing and resource estimates for cancer have not been complete
owing to lack of comprehensive data on cancer-related medication and radiation treatment …

Introduction: Costs associated with cancer care are increasing. Cancer costs in the context
of other common non-cancer diagnoses have not been extensively studied at the population …

Background The first year after cancer diagnosis is a period of intensive treatment and high
cost. We sought to estimate costs for the 21 most common cancers in Ontario in the 3-month …

Background Cancer incidence and treatment-related costs are rising in Canada. We
estimated health care use and costs in the first year after diagnosis for patients with 7 …

Background: Resource and cost issues are a growing concern in health care. Thus, it is
important to have an accurate estimate of the economic burden of care. Previous work has …

According to the Centers for Medicare & Medicaid Services (CMS), inflation-adjusted US
health care spending grew 3.9% in 2017, exceeding the US economic growth rate. 1 US …

Purpose The aim of this study was to estimate Medicare payments for cancer care during the
initial, continuing, and end‐of‐life phases of care for 10 malignancies and to examine …

Background The financial impact of cancer medicines on health systems is not well known.
We describe temporal trends in expenditure on cancer medicines within the single-payer …

Background Current estimates of the costs of cancer care in the United States are based on
data from 2003 and earlier. However, incidence, survival, and practice patterns have been …

Although many studies assessing the cost of cancer care have been conducted in the US, to
date, these studies and the underlying methods used to estimate costs have not been …